2m 2m 2m 2m 2m 2m 2m
Repligen (RGEN)
NASDAQ
$145.39+$0.51 (+0.35%)
Price as of Jul 13, 2026 7:59 PM EDT- $8.1BMarket Cap
- 19.41%1-Year Change
- Medical Instruments & SuppliesIndustry
Repligen (RGEN)
$145.39+$0.51 (+0.35%)
Earnings Score
Valuation | RGEN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | RGEN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 9.18% | ||
12-Month Momentum | 0.44% | ||
3-Month Risk Adjusted Momentum | 39.81% | ||
12-Month Risk Adjusted Momentum | 1.00% |
True Yield
Valuation | RGEN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.06% |
Financial Health Score
Valuation | RGEN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 8 |